Tag: GlobeNewswire

Board previously adopted committee charters written to Nasdaq listing standards, strengthening oversight of financial reporting, executive pay and board quality as the Company pursues its Nasdaq application

RENO, Nev., Oct. 05, 2026 (GLOBE NEWSWIRE) — Globaltech Corporation (OTCQB: GLTK) (“Globaltech” or the “Company”), a U.S.-based technology platform company enabling growth in AI, data and frontier technologies, today confirmed the composition of its three standing Board committees – the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee – and the adoption of a charter for each committee.

The charters and committee appointments were approved by unanimous written consent of the Board of Directors effective January 7, 2026, together with the Company’s Code of Ethics and Clawback Policy. The charters are written according to the independence and composition standards of the Nasdaq Capital Market.

Each committee is comprised of directors the Board has determined to be independent in accordance with Nasdaq’s rules which generally require that they are not part of the Company’s management and have no financial relationship with the Company beyond their role as directors.

The Board is chaired by James A. Gibbons, who served as the 28th Governor of Nevada from 2007 to 2011 and before that represented Nevada for five terms in the U.S. House of Representatives. An attorney by training, Governor Gibbons is also a former U.S. Air Force and Nevada Air National Guard pilot.

Committee membership

• Audit Committee: Mehdi Al Abduwani (Chair), James A. Gibbons, and David J. Fox. The Board has designated Mehdi Al Abduwani as the Committee’s audit committee financial expert.
• Compensation Committee: Charles J. Bartolotta (Chair), Mehdi Al Abduwani, and Shahid A. Khan.
• Nominating and Corporate Governance Committee: James A. Gibbons (Chair), David J. Fox, and Shahid A. Khan.

What each committee does

The Audit Committee oversees the preparation of the Company’s financial statements. It hires and supervises the independent auditor, reviews every quarterly and annual report before it is filed, monitors internal controls, approves any transaction between the Company and an insider, and maintains a confidential channel for employees to report concerns. It also oversees the Company’s cybersecurity and data-privacy risks.

The Compensation Committee establishes the pay of the Chief Executive Officer and other executive officers and recommends director compensation to the Board. It ties executive pay to performance, administers the Company’s equity plans, and oversees the Company’s clawback policy, under which certain incentive pay can be recovered if financial results are later restated. No executive takes part in decisions about his or her own pay.

The Nominating and Corporate Governance Committee decides who is nominated to serve on the Board. It sets the criteria for directors, leads the search for candidates, evaluates the performance of sitting directors each year, and keeps the Company’s governance guidelines current. Shareholders may recommend director candidates in writing to the Company Secretary.

What this means for our shareholders

In plain terms, the people who oversee the preparation of the Company’s financials, set executive pay and choose directors are now overseen by independent directors who have a fiduciary duty to the shareholders. This is the structure investors expect of a company listed on a national exchange, considered best practices and is typically required for a Nasdaq listing.

“A company earns the trust of the market one structure at a time,” said Dan Green, Chief Executive Officer of Globaltech. “Independent committees overseeing financial reporting, executive pay and board composition are the foundation of that trust. We have put them in place ahead of our planned move to a national exchange, because our shareholders should not have to wait for a listing to get that level of oversight.”

“Good governance is not a box to check. It is how a board earns the right to be trusted with other people’s money,” said James A. Gibbons, Chairman of the Board. “These committees put independent directors in charge of the questions shareholders care about most. Mehdi, Charles and I take those responsibilities seriously.”

Globaltech’s common stock was approved for quotation on the OTCQB Venture Market on March 26, 2026, and the Company completed a 1-for-3 reverse stock split on August 27, 2026.

The Company has applied to list its common stock shares on the Nasdaq Capital Market, which application is currently under review. Any listing remains subject to Nasdaq’s review, satisfaction of all applicable initial listing standards and other customary conditions, as well as Nasdaq’s discretionary approval to uplist, and there can be no assurance regarding the timing or completion of the up listing.

About Globaltech Corporation

Globaltech Corporation (OTCQB: GLTK) is a technology platform company building and commercializing AI, data and software solutions through its revenue-generating operating businesses. Its telecommunications and retail operations provide infrastructure, customer relationships and real-world environments to develop, test and scale technology platforms spanning financial technology, enterprise software, e-commerce and sports technology. Through its Center of Excellence, Globaltech evaluates, develops and commercializes technology opportunities across the platform.

For more information, please visit www.globaltechcorporation.com.

Company Contact

Dan Green
Chief Executive Officer, Globaltech Corporation
investors@globaltechcorporation.com
Toll Free: (888) 760-7067
USA: (775) 624-4817

Forward-Looking Statements

Forward-looking statements in this release include certain of the matters discussed in this communication which are not statements of historical fact constitute forward-looking statements that involve a number of risks and uncertainties, including statements regarding the Company’s planned uplisting to the Nasdaq Capital Market, its ability to satisfy Nasdaq’s initial listing requirements and obtain listing approval, and other matters. Words such as “strategy,” “expects,” “continues,” “plans,” “anticipates,” “believes,” “would,” “will,” “estimates,” “intends,” “projects,” “goals,” “targets” and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation: (a) our ability to uplist our common stock to Nasdaq, including the fact that we do not currently meet Nasdaq’s initial listing requirements, may not meet such requirements in the future, may not obtain approval of our application to list our common stock on Nasdaq on a timely basis, if at all, even if we meet all of the required quantitative listing requirements; (b) our strategic plans and treasury management initiatives; (c) risks relating to previously disclosed debt defaults and our ability to extend or refinance such debt, our need for additional capital, the terms of such capital and the potential dilution to stockholders caused thereby, including through the issuance of additional shares of common stock or upon conversion of outstanding convertible notes; (d) changes in consumer preferences, purchasing behavior, competitive conditions, and industry trends; (e) macroeconomic, geopolitical, and financial market conditions, including inflation, interest rates, tariffs, and consumer spending levels; (f) disruptions to sourcing, manufacturing, supply chain, logistics, labor availability, and the cost or availability of raw materials and finished goods; (g) the Company’s ability to successfully manage inventory, respond to changing fashion trends, maintain the strength of its brands, and execute its retail and growth strategies; (h) foreign currency exchange losses, fluctuations and translation risks related to our business in Pakistan and the United Kingdom; (i) the international economic environment, geopolitical developments and unexpected global events, including economic downturns in Pakistan, the United Kingdom and globally, changes in inflation and interest rates, tariffs, increased borrowing costs and potential declines in the availability of funding; (j) the greater political, legal and economic risks associated with operating in emerging markets as compared to more developed markets; (k) the unpredictability of our revenue performance, including because a significant majority of our customers have not entered into long-term fixed contracts with us; (l) our ability to compete in highly competitive markets, which we expect to become increasingly competitive, and our ability to expand our customer base and retain existing customers; (m) our ability to keep pace with technological changes and evolving industry standards; (n) cyber-attacks and other cybersecurity threats that may lead to compromised or inaccessible telecommunications, digital and financial services, leaks or unauthorized processing of confidential information, and the potential loss of customer confidence resulting therefrom; (o) the highly capital-intensive nature of the telecommunications industry and the substantial and ongoing capital expenditures required to operate and grow our business; (p) the terms of our interconnect agreements and our access to third-party-owned infrastructure and networks over which we have no direct control; (q) increases in license fees and our ability to obtain, maintain, renew or replace licenses, which may be suspended or revoked; (r) risks related to our ability to continue conducting our activities in a manner that does not cause us to be deemed an investment company under the Investment Company Act of 1940, as amended; (s) the loss of important intellectual property rights or third-party claims alleging infringement of intellectual property rights; (t) our substantial indebtedness and debt service obligations, which could materially decrease cash flow and adversely affect our business and financial condition; (u) our ability to maintain ownership and control of Worldcall Telecom Limited and 123 Investments Limited, as well as our status as a controlled company; (v) conflicts of interest; (w) our ability to comply with the extensive variety of laws and regulations applicable to our business and the uncertain judicial and regulatory environments in which we operate; (x) the fact that our operating subsidiaries, assets and certain of our officers and directors are located in Pakistan and the United Kingdom, which may affect shareholder rights, including the ability to enforce civil liabilities under U.S. securities laws; (y) the outcome of legal disputes, claims, investigations and litigation involving regulators, competitors and third parties; (z) risks relating to future divestitures, asset sales, joint ventures and acquisitions; (aa) the absence of an active trading market for our common stock and the risk that such a market may not develop or be sustained; (bb) future operating results; and (cc) other plans, objectives, expectations and intentions contained in this release that are not historical facts.

Other important factors that may cause actual results and outcomes to differ materially from those contained in the forward-looking statements included in this communication are described in Globaltech’s publicly filed reports, including, but not limited to, Globaltech’s Annual Report on Form 10-K for the year ended December 31, 2025, the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, future Annual Reports on Form 10-K, and Quarterly Reports on Form 10-Q. These reports are available at www.sec.gov. Globaltech cautions that the foregoing list of important factors is not complete. All subsequent written and oral forward-looking statements attributable to Globaltech or any person acting on behalf of Globaltech are expressly qualified in their entirety by the cautionary statements referenced above. Other unknown or unpredictable factors also could have material adverse effects on Globaltech’s future results. The forward-looking statements included in this press release are made only as of the date hereof. Globaltech cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Globaltech undertakes no obligation to update these statements after the date of this release, except as required by law, and takes no obligation to update or correct information prepared by third parties that are not paid for by Globaltech. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

VANCOUVER, British Columbia, Oct. 05, 2026 (GLOBE NEWSWIRE) — Cambria Gold Mines Inc. (TSXV: CAMB; OTCQX: CAMVF) (“Cambria” or the “Company”) is pleased to provide a status update of ongoing construction, development, permitting, Feasibility Study preparation and infill drilling progress from the Premier Gold Project (“PGP” or the “Premier Project”) and Red Mountain Gold Project (“Red Mountain”), located near Stewart in northwestern British Columbia, as well as additions to its engineering and operational team. The Company is targeting commissioning of the 2,500 tonne per day mill at PGP in Q4 of 2027 with continued ramp up through 2028. Additionally, the Company is pleased to announce that over CA$45.9 million has been received through the exercise of outstanding warrants.

“Cambria continues to advance operational permitting, infill drilling, engineering and construction activities at PGP and Red Mountain, de-risking critical components to facilitate mining and processing in late 2027. Sufficient mineralization is accessible at PGP to commence mining, which would be subsequently augmented by Red Mountain once construction is complete,” said Robert McLeod, President and CEO of Cambria Gold Mines. “The Red Mountain Access Road construction is advancing very well and we are pushing to achieve access to Bromley Humps by the end of 2026.”

“As we complete additional development and prepare for operation readiness, our ability to attract exceptional engineers, such as: Ali Farah, Carla Romero, Brandon Chambers and Dinesh Devathasan, is driven by the quality of our gold projects and by our positive, supportive and determined team,” said Gord Doerksen, VP Projects of Cambria Gold Mines. “Our construction team has made strong headway in all facets, and our new engineering strength will set us up well for continued project development in 2027, with particular emphasis on planning and engineering, as well as water management and treatment and PGP.”

Red Mountain Access Road

The final Permit for the Red Mountain access road, a Fisheries Act Authorization (FAA), was received on September 21, 2026, allowing for in-stream construction work to be performed in Bitter Creek, rebuilding sections of a previous road that was washed away during a storm event in 2013.   With the FFA in hand, Cambria’s construction team and road building contractor are advancing the road expeditiously and safely toward our goal of reaching the Bromley Humps area near the base of Red Mountain, roughly 12 km from Highway 37A.

The alpine portion of the road to access the Red Mountain deposit is anticipated to be built during the 2027 construction season. The Company’s objective is to truck mill feed material to the mill at PGP, a distance of approximately 50 km, through the communities of Stewart and Hyder.

Additionally, the Company is studying bulk material transport options: an aerial tramline or rope conveyor from the Red Mountain Deposit to the Bitter Creek valley, which would be installed after the road is completed, likely following the first year of operations. These aerial conveyance systems have historically been used extensively in the region and modern systems have proven very successful globally.    

Figure 1. Red Mountain Access Road and Armouring adjacent to Bitter Creek

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4ccffa12-70de-46df-8bcc-d0da769e2743

Resource Modelling and Infill Drilling

To inform the updated Feasibility Study, the Company has built a comprehensive geological and assay database, remodelling the geology and mineralized zones of the PGP deposits with the purpose of informing an updated Mineral Resource and Reserve Estimate. The current Resource and Reserve Estimate, last updated in 2021, was modelled using grade shells rather than following geological units. Starting from first principles, Cambria’s geological team has been remodelling the major and peripheral deposits at PGP, integrating both new and historical data from over 100 years of mining history from multiple epithermal deposits.

Both the Big Missouri and Silver Coin Deposits, previously mined by Cominco and Westmin/Tenajon Resources were wide breccia and vein stockwork structures mined using longhole underground techniques. Cambria has modelled these structures as well as post mineral faults and dykes with the objective of outlining bulk mineable areas; infill drilling has been ongoing at both areas to increase confidence in grade and structure. Emphasis has been on the Silver Coin deposit, which has higher grades than Big Missouri, can be mined using productive longhole mining methods, and will be the primary focus for the restart along with the high-grade Premier deposit.

At the Premier Deposit, extensive infill drilling work on 12.5 metre spacing targeting high-grades within the Prew and 602 Zones has been prioritized. Once underground development has recommenced in Q4 2026, additional underground drilling will be completed to continue defining Measured Resources that could potentially convert to Proven Reserves and be accessed in the early years of the operation. This material would be blended with wide and continuous mineralization from Silver Coin and Big Missouri while the Red Mountain Deposit is developed.

Feasibility Study Update

Cambria continues to advance an updated Red Mountain-PGP Feasibility Study to capture the value of the combined project, with targeted completion in H1 2027. SLR Advisors, a global mining consultancy, has been engaged to be the primary author with support from QPs from other specialists in their respective fields.

As discussed in recent releases, the Feasibility Study work is informed by an extensive infill drilling program at PGP to provide robust resource confidence, as well as new metallurgical testing, mine plan optimization, and processing plant modifications to treat mineralized material from both projects. No additional infill drilling has been required at the Red Mountain Deposit.

Water Treatment Plant

At PGP, the priority work on the site has been water management and the water treatment plant. Since construction in 2024, the Water Treatment Plant (“WTP”) continually struggled with discharge compliance for zinc. Through a series of focused initiatives, expedited with urgency, the Company is advancing closer to compliance with results improving in the past two months. Extensive efforts have fixed many of the WTP’s operational problems, including taking over control of plant operations with in-house personnel (previously managed and operated by a contractor), engaging specialized water treatment consultants for guidance and activating better process controls. Cambria’s team completed extensive upgrades and additions to pumps, valves, pipes and various equipment that were in various stages of neglect. The Company also updated a water balance to better understand the entire water system and how best to manage and treat contact water.

Figure 2. New Upper Sediment Pond Liner at PGP Water Treatment Plant

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8f2b01b7-0e2e-4133-9893-946d7f267244

Mining

Cambria is currently upgrading underground infrastructure at Premier-Northern Lights with brow support, power upgrades, a ventilation bulkhead, water management sumps and secondary egress. These improvements will be complete by the end of 2026 and will allow us to begin additional development for stope access for mining and additional platforms for further infill drilling.  Underground work will be completed using Cambria’s newly purchased and commissioned fleet of mining equipment including LHDs, a twin-boom face jumbo, scissor deck and service vehicles. Additionally, underground development at the Silver Coin deposit will take place in the spring of 2027 to create development for operations. Accessing Silver Coin will be from the recently constructed underground workings at the Big Missouri deposit, 700 metres north of Silver Coin or from a new portal location closer to the mineralized zones, based on permitting considerations. Cambria’s remodelling of the Big Missouri Deposit has also identified the potential for several small open pit, that will be further evaluated as part of the Feasibility Study.

2026 geotechnical drilling at new Silver Coin and Red Mountain portal locations will assist in detailed portal design. All deposits benefit from previous underground development accelerating our development plan and reducing anticipated restart capital costs.

Premier Mill Upgrades

Detailed planning and budgeting of the Premier processing plant upgrades are underway with engineering, procurement and installation work. The mill operated as recently as 2025 and is in excellent condition. Based on past operating knowledge, the program includes some additional optimizations. These critical improvements include the installations of a new primary jaw crusher and feeder. The crusher building, covered crushed material stockpile and conveyor system, dating to the 1990’s operations are in excellent condition, with just the mechanical and electrical components required. Additional immediate upgrades will include converting an unused clarifier to a pre-leach thickener. Prior to introduction of material from Red Mountain, a fine grinding mill and second detox tank will be added. All required mill upgrades for restarting with Premier material will be completed in 2027.

Additions to Cambria’s Operating Team

To plan and execute on the Company’s re-start preparations, Cambria is pleased to announce the expansion of our project team with the addition of four exceptional people to the engineering team.

Ali Farah, P.Eng., a highly experienced Mechanical Engineer and Manager with over 35 years of experience, has joined Cambria as Director of Engineering responsible for all engineering activities for the Project. Ali will oversee all technical work done by consultants and in-house personnel to maintain high engineering standards, align all engineering work and ensure the greatest efficiency of design and execution. He will be a key piece of our strategic and tactical planning. Ali has a decade of experience in northwest BC mining in addition to +20-years of various technical and management roles in mining and other industries.  

Carla Romero Robiero, P.Eng. joined as Cambria’s Environmental Manager, with a primary focus on water system compliance, monitoring and reporting. Carla has 20 years of experience and was most recently the Senior Lead, Water Integrated Planning with a major mining company. She integrates water balance, water quality, treatment, mine planning, and financial analysis to guide assets toward resilient, low-risk outcomes.

Brandon Chambers, P.Eng. recently joined as our new Manager of Engineering. Brandon is a Mining Engineer with a broad range of operational, planning and construction experience. Brandon is an accomplished problem solver, planner and leader and will be extremely valuable providing guidance and knowledge to the wide range of initiatives Cambria is pursuing as well as providing engineering controls for our improvement plans.

Dinesh Devathasan, P.Eng. recently joined as our Underground Manager, who will lead Cambria’s team as underground development is advanced that takes the Company to production. Dinesh has proven, relevant experience in taking underground mining projects into successful, producing mines. Dinesh’s experience spans technical and management roles giving him the holistic knowledge needed to ensure a successful restart of Cambria’s mining assets. Dinesh has many years of Golden Triangle operating experience including at the Brucejack Mine.

Permitting

The Company achieved a significant permitting milestone in 2026 with the receipt of all permits required for construction of the Red Mountain access road. In parallel, Cambria is advancing engineering and environmental programs to support submission of the proposed haul road permit application. Baseline environmental studies were also conducted throughout 2026 at both the Premier and Red Mountain projects to validate and supplement existing environmental baseline information, while supporting ongoing project planning and future permitting requirements.

Looking ahead, the Company’s permitting efforts will focus on advancing the major mine authorizations required for the construction and operation of both the Premier and Red Mountain projects. At Red Mountain, ongoing engineering, environmental, and technical studies are also supporting an amendment to the existing Environmental Assessment Certificate to reflect the current project design and development plan. The Company continues to work collaboratively with regulatory agencies, Indigenous interests, and local stakeholders to advance these permitting processes.

Issuance of Interest Shares to Nebari

Further to the Company’s December 30, 2025 press release, and in connection with the second amended and restated facility agreement with Nebari Natural Resources Credit Fund II, LP and Nebari Gold Fund 1 LP, as lenders (the “Lenders”), and Nebari Collateral Agent LLC, as collateral agent (the “Collateral Agent”, and, together with the Lenders, “Nebari”) dated December 30, 2025 (the “Convertible Facilities”) and the third amended and restated cost overrun agreement entered into with Nebari dated December 30, 2025 (the “COF”), the Company intends to settle quarterly interest for the period beginning July 1, 2026 and ending September 30, 2026 of $1,800,253.06 payable to Nebari through the issuance of an aggregate of 2,017,318 common shares at a deemed price rounded to $0.892 per share, subject to approval of the TSX Venture Exchange. The interest has been calculated in accordance with the rates specified in the COF and Convertible Facilities.

All amounts are shown in Canadian dollars and Nebari is an arm’s length creditor to the Company.

Qualified Person and Technical Information:

The scientific and technical information within this news release was reviewed and approved by Gord Doerksen, P.Eng., Vice President of Projects for Cambria Gold Mines Inc. Mr. Doerksen is a non-independent “Qualified Person” as defined under National Instrument 43-101.

About Cambria Gold Mines

Cambria Gold Mines is a Canadian mining company headquartered in Vancouver, British Columbia, and its shares trade on the TSX-V under the ticker CAMB and on the OTCQX Market with the ticker CAMVF. Cambria is the 100% owner of the Premier Project and Red Mountain Gold Project that are located on Nisga’a Nation Treaty Lands, in the prolific Golden Triangle of northwestern British Columbia, as well as the large Mt. Margaret copper-gold porphyry deposit located in Washington State. For more information about the Company, please refer to the Company’s profile on SEDAR+ at www.sedarplus.ca or visit the Company’s web site at www.cambriagold.com.

On behalf of the Board of Directors of Cambria Gold Mines Inc.

Robert McLeod
CEO and Director 

For further information contact:

Email: info@cambriagold.com
Phone: 778-725-1060

and:

Sam Brezden
Email: sam.brezden@cambriagold.com
Phone: 236-838-1840

Or visit:

https://cambriagold.com/

Cautionary Statements:

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Cautionary Statement Regarding Forward-Looking Information
All statements and other information contained in this press release about anticipated future events may constitute forward-looking information under Canadian securities laws (“forward-looking statements”). Forward- looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “targeted”, “outlook”, “on track” and “intend” and statements that an event or result “may”, “will”, “should”, “could”, “would” or “might” occur or be achieved and other similar expressions. All statements, other than statements of historical fact, included herein are forward-looking statements, including statements in respect of the targeted commissioning of the goals for the tonnes per day at PGP; the results and timing of the ramp up; the timing and completion of the access road construction; drill results resulting in actual increases of resources and reserves; the timing and certainty of the restart of the Premier mill and mining operations at the Premier and Red Mountain Projects; the timing and outcome of additional assay results; the timing and outcome of the updated Feasibility Study, the timing and completion of the Premier Mill upgrades; the receipt of the TSX Venture Exchange approval for the issuance of interest shares to Nebari; ability of the Company to accomplish its business objectives and the intentions described herein; and future plans, development and operations of the Company. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements; risks relating to negative operating cash flows of the Company; business and economic conditions in the mining industry generally; fluctuations in commodity prices and currency exchange rates; environmental compliance; risks related to outstanding debt; uncertainty of estimates and projections relating to development, production, costs and expenses, and health, safety and environmental risks; uncertainties relating to interpretation of drill results and the geology, continuity and grade of mineral deposits; the need to obtain additional financing to finance operations and uncertainty as to the availability and terms of future financing; social media and reputation; negative publicity; human rights; business objectives; shortage of personnel; health and safety; the possibility of delay in future plans and uncertainty of meeting anticipated program milestones; claims and legal proceedings; information systems and cyber security; internal controls; violation of anti-bribery or corruption laws; competition; tax considerations; compliance with listing standards; enforcement of civil liabilities; financing requirement risks; market price volatility of the common shares; uncertainty as to timely availability of permits and other governmental approvals; the need for exchange approval, and other regulatory approvals and other risk factors as detailed from time to time in Cambria’s filings with Canadian securities regulators, available on Cambria’s profile on SEDAR+ at www.sedarplus.ca including the Annual Management Discussion and Analysis of the Company for the year ended December 31, 2025 in the section entitled “Risk Factors”. Forward-looking statements are based on assumptions made with regard to: the estimated costs associated with the care and maintenance plans; the tax rate applicable to the Company; future commodity prices; the grade of mineral resources and mineral reserves; labor and materials costs increasing on a basis consistent with the Company’s current expectations, the ability of the Company to convert inferred mineral resources to other categories; the ability of the Company to reduce mining dilution; the ability to reduce capital costs; the ability of the Company to raise additional financing; currency exchange rates being approximately consistent with current levels, compliance with the covenants in Cambria’s credit agreements; exploration plans; and general marketing, political, business and economic conditions. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Although Cambria believes that the expectations reflected in such forward-looking statements and/or information are reasonable, undue reliance should not be placed on forward-looking statements since Cambria can give no assurance that such expectations will prove to be correct. Cambria does not undertake any obligation to update forward-looking statements, other than as required by applicable laws. The forward-looking information contained in this press release is expressly qualified by this cautionary statement.

Tryg has compiled consensus estimates ahead of the Q3 2026 report. Consensus is based on input from 16 financial analysts.

Consensus is also available on tryg.com.

Attachment

• Q3 2026 – Consensus

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:	Investec Bank Plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Advanced Medical Solutions Group Plc
(c)        Name of the party to the offer with which exempt principal trader is connected:	Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc
(d)        Date dealing undertaken:	02nd October 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state “N/A”	N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchases/ sales	Total number of securities	Highest price per unit paid/received	Lowest price per unit paid/received
Ordinary shares	Purchase	12,004	282	282
Ordinary shares	Sales	15,073	282.25	282.25

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
N/A	N/A	N/A	N/A	N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit
N/A	N/A	N/A	N/A	N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
N/A	N/A	N/A	N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)        the voting rights of any relevant securities under any option; or (ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

Date of disclosure:	05th October 2026
Contact name:	Abhishek Gawde
Telephone number:	+91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:	Investec Bank plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Gooch & Housego plc
(c)        Name of the party to the offer with which exempt principal trader is connected:	Investec is Advisor and Broker to Gooch & Housego plc
(d)        Date dealing undertaken:	02nd October 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state “N/A”	N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchases/ sales	Total number of securities	Highest price per unit paid/received	Lowest price per unit paid/received
Ordinary shares	Purchases	55,563	1225.5	1225
Ordinary shares	Sales	69,205	1230	1225

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
N/A	N/A	N/A	N/A	N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit
N/A	N/A	N/A	N/A	N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
N/A	N/A	N/A	N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)        the voting rights of any relevant securities under any option; or (ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

Date of disclosure:	05th October 2026
Contact name:	Abhishek Gawde
Telephone number:	+91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SHENZHEN, China, Oct. 05, 2026 (GLOBE NEWSWIRE) — Jiuzi Holdings, Inc. (NASDAQ: JZXN) today provided a comprehensive update on the latest strategic positioning and future commercial prospects of its AI smart imaging and data platform. The Company confirmed that the platform is accelerating its evolution toward a unified, modular, and scalable enterprise-grade solution, with the potential for broad commercial deployment across multiple high-value scenarios, including smart retail, intelligent security, media content management, remote inspection, and advanced driver assistance. The Company maintains its guidance of approximately US1.55 million, would represent a fundamental reshaping of its revenue structure.

Platform Positioning Upgrade: From AI Recognition Module to Enterprise-Grade Infrastructure

Jiuzi Holdings’ AI smart imaging platform is completing a fundamental leap in capabilities. According to the Company’s strategic plan, the platform will no longer be a standalone image recognition tool, but a unified solution covering the entire workflow from data collection and algorithm processing to scenario applications and business decision support. This architecture deeply integrates multi-layered data structures and algorithmic capabilities, enabling the platform to transform complex image data into actionable business insights, helping customers improve operational efficiency and unlock additional value from their data assets.

Hongye Zhang, Chief Executive Officer of Jiuzi, said: “By working closely with professional AI technology partners, we will significantly enhance the technical depth and scenario adaptability of our smart imaging and data solutions, delivering more efficient, secure, and implementable AI services to global markets.” Management further noted that as the platform’s capabilities continue to evolve, the AI smart imaging system is expected to achieve broader customer adoption in North America and global markets, supporting commercialization across multiple industry scenarios.

Future Outlook: Multi-Scenario Coverage and Global Market Expansion

Looking ahead to the commercial form of the platform once mature, Jiuzi Holdings is systematically evaluating its application potential across multiple core industries. In smart retail, the platform is expected to help retailers optimize inventory management and customer experience through real-time image recognition and dynamic scenario analysis. In intelligent security, the platform’s multimodal data fusion and automated content tagging capabilities can support more efficient real-time monitoring and alert systems. In addition, the Company is working with technology partners to explore image data authentication, copyright protection, and distributed storage products in Web3 and blockchain infrastructure, preparing for future decentralized application scenarios.

At the technical deployment level, Jiuzi is focused on optimizing standardized interfaces and solution architecture, with the goal of enabling lower integration barriers and shorter deployment cycles when delivering the platform to enterprise customers, thereby accelerating the transition from pilot validation to large-scale commercial deployment. The Company believes that enterprise demand for smart imaging systems is shifting from validation of single algorithm functions to scalable, compliance-ready integrated platform architectures, and this trend is the core rationale behind Jiuzi’s platform strategy.

Million-Dollar Profit Expectation Anchors Commercial Value; Market Growth Provides Long-Term Support

Jiuzi Holdings previously disclosed that, subject to the formal advancement of relevant business arrangements, the initial stage is expected to contribute approximately US1.55 million, if realized, this profit magnitude would have a fundamental impact on the Company’s overall financial condition. Zhang noted: “If the expected profit contribution from the initial cooperation stage is realized, it will fully demonstrate the commercial potential of our AI strategy and provide an important foundation for the expansion of subsequent projects.”

From the broader market perspective, Jiuzi’s platform commercialization path has solid industry growth support. The global AI image recognition market is expected to grow from approximately US11.07 billion in 2031, representing a compound annual growth rate of approximately 14.31%. Meanwhile, the AI imaging software and services sector is experiencing rapid growth, with the AI vision software subsegment expected to reach approximately US$23.6 billion by 2032, growing at a CAGR of approximately 19.9%. As digital infrastructure upgrades accelerate, enterprise demand for smart imaging systems is shifting from experimental validation to large-scale deployment, and Jiuzi’s platform-level positioning is closely aligned with this industry trend.

AI Roadmap Progresses Clearly; Commercialization Inflection Point Approaches

Reviewing the pace of Jiuzi Holdings’ AI strategy: in May 2026, it completed the establishment of a technical cooperation framework; in June 2026, it confirmed platform milestone progress; in July 2026, it clarified its million-dollar profit expectation; and in September 2026, it advanced system validation and commercial deployment preparation. These milestones demonstrate that the Company is advancing its AI business in a phased, prudent, and steady manner. As the platform architecture continues to improve and its multi-scenario adaptability strengthens, Jiuzi’s AI smart imaging platform is establishing a solid technical and operational foundation for entering the scenario-based deployment stage with its first enterprise customers, and the million-dollar initial profit target will face substantive testing.

About Jiuzi Holdings, Inc.

Jiuzi Holdings, Inc. is a Chinese company primarily engaged in the new energy vehicle retail business. It operates “Jiuzi”-branded stores, selling battery electric vehicles and plug-in hybrid electric vehicles, and is also involved in the franchising of new energy vehicle retail stores. The Company is actively expanding its technology business footprint through strategic initiatives such as its AI smart imaging and data platform, driving diversified upgrading of its business structure.

Forward-Looking Statements

The platform development prospects and expected commercialization profits in this press release are subject to multiple conditions, including technology validation results, the actual advancement of business arrangements, project implementation, customer acceptance, and collection of payments. The Company cannot guarantee that the platform will complete all technical assessments as expected, that relevant business arrangements will proceed as planned, that the initial profit target will be achieved, or that the platform will enter the large-scale commercial deployment stage within the expected timeframe. The ultimate deployment scale, customer adoption, and commercial contribution of the AI smart imaging platform will depend on technological progress, market demand, partners’ execution capabilities, project implementation, and other commercial factors.

Media Contact:

coco@jzxn.com 

Project will deliver high-speed connectivity to public institutions and communities

PETAH TIKVA, Israel, Oct. 05, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Peruvian subsidiary, Gilat Perú, has signed a $28 million agreement with Pronatel (Programa Nacional de Telecomunicaciones), Peru’s national telecommunications program, to upgrade broadband connectivity across the Ica region. The project’s construction is expected to be completed by mid-year 2027 followed by a seven-year operational phase.

The Ica project marks the fifth region in Peru to receive a broadband network upgrade since 2025. The upgraded network will deliver internet speeds 20 times faster than those currently available to 116 public institutions across the Ica region and provide free Wi-Fi access in 30 public squares. The upgrade will strengthen the network’s capacity to meet the connectivity needs of institutions across different locations and operating environments and support their ability to access and deliver essential digital services, including education, healthcare, and public safety. The improved network infrastructure will also provide a stronger foundation for institutions to meet the region’s evolving connectivity needs.

“This project to increase connectivity speeds in Ica will strengthen connectivity for public institutions and expand free internet access for citizens. Through PRONATEL, the Ministry of Transport and Communications continues to advance initiatives aimed at translating greater connectivity capacity into better services and opportunities for people, helping to bridge the digital divide,” said Rafael Arias Velarde, Executive Director of PRONATEL.

“Strong connectivity is essential to enabling public institutions and communities to access digital services and opportunities,” said Arieh Rohrstock, President, Gilat Perú. “Gilat Perú has built this expertise through years of deploying, upgrading and operating large-scale networks across the country. We are proud to bring that experience to Ica, strengthening the infrastructure that connects public institutions and expanding internet access for communities across the region.”

The project builds on Gilat Perú’s extensive experience deploying, upgrading and operating large-scale telecommunications networks across the country, including in rural and geographically diverse areas. Its capabilities across the lifecycle of regional networks, from deployment and modernization to ongoing operation, enable Gilat Perú to address different geographic and operational requirements and manage large-scale connectivity infrastructure across diverse environments.

About Gilat

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With over 35 years of experience, we develop and deliver deep technology solutions for satellite, ground, and new space connectivity, offering next-generation solutions and services for critical connectivity across commercial and defense applications. We believe in the right of all people to be connected and are united in our resolution to provide communication solutions to all reaches of the world.

Together with our wholly owned subsidiaries Gilat Wavestream, Gilat DataPath, and Gilat Stellar Blu, we offer integrated, high-value solutions supporting multi-orbit constellations, Very High Throughput Satellites (VHTS), and Software-Defined Satellites (SDS) via our Commercial and Defense Divisions. Our comprehensive portfolio is comprised of a software-defined platform and modems, high-performance satellite terminals, advanced Satellite On-the-Move (SOTM) antennas and Electronically Steered Antennas (ESAs), highly efficient, high-power Solid State Power Amplifiers (SSPA) and Block Upconverters (BUC) and includes integrated ground systems for commercial and defense markets, field services, network management software, and cybersecurity services.

Gilat’s products and tailored solutions support multiple applications including government and defense, IFC and mobility, cellular backhaul, enterprise, aerospace and critical infrastructure clients all while meeting the most stringent service level requirements. For more information, please visit: https://www.gilat.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and can generally be identified by the use of forward-looking terminology such as “estimate,” “project,” “intend,” “expect,” “believe,” “anticipate,” “plan,” “may,” “will,” “seek,” “could,” “should,” or similar expressions. These forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements of Gilat to differ materially from those expressed in, or implied by, such statements. These risks and uncertainties include, among others, changes in general economic, market and business conditions; failure to maintain market acceptance of Gilat’s products; failure to timely develop and introduce new technologies, products and applications; rapid changes in the markets in which Gilat operates; increased competition, loss of market share or pressure on prices; loss of key OEM partners; inability to attract and retain qualified personnel; inability to protect proprietary technology; and risks associated with Gilat’s international operations and its location in Israel, including those arising from regional military conflicts and geopolitical instability. For additional information regarding these and other risks and uncertainties, please refer to Gilat’s filings with the U.S. Securities and Exchange Commission. Gilat undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Gilat Satellite Networks
Hagay Katz, Chief Products and Marketing Officer
PublicRelations@gilat.com

Phased Production Model with Staggered Rearing Schedules Keeps Operations Running Continuously, Positioning Kraig Labs to Meet Future Commercial Demand

ANN ARBOR, Mich., Oct. 05, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its September/October production cycle is well underway, with all three production centers running. Early reports indicate the Company is on track for another successful rearing cycle.

The announcement comes just days after Kraig Labs fulfilled its first purchase order from the performance sportswear segment, shipping custom recombinant spider silk yarn to a globally recognized brand. That delivery marked the Company’s transition from production milestones to commercial deliveries. This last cycle is further evidence of the production engine behind that milestone. Kraig Labs has built a reliable production platform capable of sustaining commercial-scale levels of spider silk to the market.

“Our team in Vietnam is executing well, and the early indicators for this cycle are encouraging,” said Kim Thompson, Founder and CEO of Kraig Labs. “All three centers are up and running on schedule. That matters now, more than ever. We are no longer producing to demonstrate and confirm scale. Production is now focused on addressing the commercial market opportunities for spider silk.”

Kraig Labs uses genetically engineered silkworms to produce silk containing key spider silk proteins. A “rearing cycle” involves raising a batch of silkworms from hatching through cocoon formation. The current cycle focuses on the Company’s parental strains, which are the breeding lines used to produce hybrid silkworm eggs. Silkworms hatched from those eggs subsequently produce the silk cocoons that are processed into yarn.

“Running three centers on phased schedules isn’t just about volume,” Thompson continued. “It’s about building an operation that is resilient at high volume. One center can be in early rearing while another is deep into production and a third is preparing for harvest. That overlap gives us continuous output and real redundancy. If one center faces a disruption, the other two keep moving.”

Kraig Labs’ three production centers each run their own rearing cycle on a staggered schedule, so the facilities are at different stages of development at any given time. This approach maintains a steady supply of hybrid eggs for subsequent silk production while reducing reliance on any single facility.

That redundancy has taken on added significance following the Company’s last production run. Kraig Labs grew silk production by more than 30% through the rainy season, historically one of the most difficult stretches of the year. Management believes the phased model was a key factor behind that result. This system continues to elevate Kraig’s operations with a growing supply line of spider silk available to address opportunities for additional commercial orders.

Thompson concluded, “A continuous, redundant production model is what positions Kraig Labs to move quickly when new opportunities arise. Three centers, three schedules, one continuous operation, prepared for the opportunities ahead.”

The Company’s leadership in biomaterials was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of our work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering

You can see Kraig Labs featured in Veritasium’s spider silk video at https://www.youtube.com/watch?v=wt4p2oalmRY

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ab747743-744f-4ffd-bac0-9d6cad3dabec

ATH434 50 mg significantly slowed functional decline in MSA by approximately 52% versus placebo on the 11-item UMSARS at Week 52 with CSF NfL as a covariate 

Baseline CSF NfL predicted the rate of functional decline, supporting its use as a severity covariate in Phase 3

MELBOURNE, Australia and SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that additional analyses from its randomized, double-blind, placebo-controlled ATH434-201 Phase 2 trial in Multiple System Atrophy (MSA) were presented at the 2026 International Congress of Parkinson’s Disease and Movement Disorders (MDS Congress) in Seoul, Korea. The poster brings together clinical, biomarker, and imaging results from the trial after adjusting for baseline disease severity, measured by cerebrospinal fluid neurofilament light chain (CSF NfL).

“These additional analyses strengthen our confidence in ATH434 as a potential disease-modifying therapy for MSA. When we account for differences in baseline disease severity using CSF NfL, ATH434 50 mg significantly slowed functional decline by more than 50% compared with placebo over one year, a treatment effect well above the threshold considered clinically meaningful,” said David Stamler, M.D., CEO.

“I continue to be impressed by the strength of the efficacy signal in our Phase 2 study in the context of other treatments that are in development for MSA. By incorporating the learnings regarding NfL into our Phase 3 confirmatory trial, we continue to build on our de-risking strategy that has been so successful in Phase 2,” concluded Dr. Stamler.

The poster, entitled, “ATH434 in Multiple System Atrophy: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study with CSF Neurofilament Light Chain as a Disease Severity Covariate,” analyzed baseline CSF NfL, an established prognostic biomarker of clinical decline in MSA, as a covariate to account for variability in baseline disease severity.

The analysis demonstrated that CSF NfL, a prespecified covariate in the Phase 2 trial, predicts functional decline in individuals with MSA. Higher baseline CSF NfL predicted greater decline at Week 52: each 1,000 pg/mL increase was associated with approximately 0.9 additional points of worsening on UMSARS I¹, an effect that was significant (p=0.033). This supports using CSF NfL as a covariate in future MSA trials since adjusting for a known predictor of decline can produce a more precise measurement of treatment effect.

ATH434 50 mg significantly slowed functional decline on the 11-item UMSARS Part I

The analysis utilized a mixed model for repeated measures (MMRM)² applied to align with the imaging analyses conducted on the Modified Intent-to-treat (mITT) population (N=61)³. After adjustment for baseline CSF NFL, ATH434 50 mg significantly slowed functional decline on the 11-item UMSARS Part I⁴ at Week 52 with a −4.64-point difference versus placebo in change from baseline (p=0.032), roughly 3-fold more improvement compared to the 1.5-point minimal clinically important difference (MCID). This represents an approximate 52% slowing of functional decline in the 50 mg dose group relative to placebo. The 75 mg dose also slowed functional decline with a −2.81-point difference versus placebo in change from baseline at Week 26 (p=0.072) and Week 52 (p=0.179). These results are consistent with the previously reported analysis of the 11-item UMSARS Part I in the Phase 2 clinical analysis population, in which ATH434 50 mg slowed decline by 46% versus placebo (p=0.037). The difference between the two figures reflects the distinct analysis populations and statistical models.

Advanced brain iron MRI imaging is consistent with the ATH434 mechanism of action as an iron-chaperone

The poster also reported brain iron measured by quantitative susceptibility mapping (QSM) MRI analyzed with the same CSF NfL-adjusted model. ATH434 is designed as an iron chaperone and is intended to redistribute reactive (labile) iron that is driving MSA pathology. MRI can detect iron leaving cells but cannot measure iron that has been stored or buffered within cells. Although the trial’s primary endpoint of change in substantia nigra iron at Week 52 was not met, change from baseline in iron was numerically lower in the putamen and globus pallidus with ATH434 vs placebo. In the dentate nucleus, iron signal increased relative to placebo at Week 52 (50 mg: +0.016 ppm, p=0.021), which is hypothesized to reflect redistribution of mobilized iron through the brain’s glymphatic system. The poster noted that regional differences may reflect region-specific iron handling because an MRI captures iron efflux but not the potential storage or buffering effects of ATH434.

The presentation is available on the Alterity Therapeutics website here.

About ATH434-201 Phase 2 Clinical Trial 

The ATH434-201 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of 12 months treatment with ATH434 in patients with MSA. The study evaluated the efficacy, safety and pharmacokinetics of ATH434 as well as the effect of ATH434 on neuroimaging and protein biomarkers. Wearable sensors were employed to evaluate motor activities outside of the clinic. The study enrolled 77 adults who were randomly assigned to receive ATH434 50 mg or 75 mg twice daily or matching placebo. The data showed that, compared to placebo, ATH434 50 mg produced clinically and statistically significant slowing of decline on the 11-item Unified Multiple System Atrophy Rating Scale (UMSARS) Part I, a functional rating scale that assesses disability on activities of daily living affected in MSA. Additional efficacy assessments demonstrated improvement consistent with the positive UMSARS Part I findings including trends in improved motor performance on the Clinical Global Impression of Severity Scale, the Swallowing Disturbance Questionnaire and the Orthostatic Hypotension Symptom Assessment. Wearable sensor data indicated that ATH434 also led to increased activity in an outpatient setting. Biomarkers were used to evaluate potential drug effect and target engagement relative to placebo. Both dose levels reduced iron accumulation in MSA affected brain regions with trends in preservation of brain volume. ATH434 was well tolerated with similar adverse event rates compared to placebo and no serious adverse events attributed to ATH434. Additional information on the Phase 2 trial can be found by ClinicalTrials.gov Identifier: NCT05109091.

About Multiple System Atrophy

Multiple System Atrophy (MSA) is a rare, neurodegenerative disease characterized by failure of the autonomic nervous system and impaired movement. The symptoms reflect the progressive loss of function and death of different types of nerve cells in the brain and spinal cord. It is a rapidly progressive disease and causes profound disability. MSA is a Parkinsonian disorder characterized by a variable combination of slowed movement and/or rigidity, autonomic instability that affects involuntary functions such as blood pressure maintenance and bladder control, and impaired balance and/or coordination that predisposes to falls. A pathological hallmark of MSA is the accumulation of the protein α-synuclein within glia, the support cells of the central nervous system, and neuron loss in multiple brain regions. MSA affects up to 50,000 individuals in the U.S., and while some of the symptoms of MSA can be treated with medications, currently there are no drugs that are able to slow disease progression and there is no cure.⁴

About Alterity Therapeutics Limited

Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company is focused on developing disease modifying therapies in Multiple System Atrophy (MSA) and related Parkinsonian disorders. Alterity is preparing to initiate a Phase 3 pivotal trial in MSA, a rare and rapidly progressive disease. ATH434, the Company’s lead asset, has demonstrated clinically meaningful efficacy in a randomized, double-blind, placebo-controlled Phase 2 clinical trial in participants with MSA. Alterity has further reported positive data in its open label Phase 2 clinical trial in participants with advanced MSA. In addition, Alterity has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company’s website at https://alteritytx.com.

References:
¹ UMSARS: 11-item Unified Multiple System Atrophy Rating Scale Part I (excludes sexual function)
² Mixed Models for Repeated Measures (MMRM) analysis using all visits without imputation (treatment, visit, treatment-by-visit interaction, sex; covariates age, baseline score, baseline CSF NfL), added post hoc to align with the imaging analyses; the prespecified analysis was a Week 52 Analysis of Covariance (ANCOVA).
³ Modified Intent-to-treat (mITT) population (N=61): randomized and dosed, CSF α-synuclein seed amplification assay positive, with ≥1 postbaseline QSM assessment.
⁴ Multiple System Atrophy | National Institute of Neurological Disorders and Stroke (nih.gov)

Authorisation & Additional information
This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.

Contacts:

Investors
Elyse Shapiro
ir@alteritytx.com

Remy Bernarda
Investor Relations Advisory Solutions
ir@alteritytx.com
+1 (415) 203-6386

Media
Melissa Tempra
NWR Communications
melissa@nwrcommunications.com.au

Casey McDonald
Tiberend Strategic Advisors, Inc.
cmcdonald@tiberend.com
+1 (646) 577-8520

Schindellegi, Switzerland – 5 October 2026

Trifork Group AG
Company announcement no. 61/2026

Weekly report on share buyback

On 27 February 2026, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 2 March 2026 up to and including no later than 31 December 2026. For details, please see company announcement no. 15 of 27 February 2026.

Under the share buyback program, Trifork will purchase shares for up to a total of DKK 75 million (approximately EUR 10 million).

Under the program, the following transactions have been made:

Date	Number of shares	Average purchase price (DKK)	Transaction value (DKK)
Total beginning	532,184	100.00	53,216,166
28 September 2026	3,500	102.00	357,000
29 September 2026	3,600	101.42	365,112
30 September 2026	3,600	101.39	365,004
1 October 2026	3,500	101.09	353,815
2 October 2026	1,693	101.02	171,027
Accumulated	548,077	100.04	54,828,124

A detailed overview of the daily transactions can be found here: https://investor.trifork.com/trifork-shares/.

With the transactions stated above, the total accumulated amount of treasury shares acquired under the current share buyback program corresponds to 2.8% of the share capital of Trifork Group AG. Trifork Group owns 814,493 treasury shares in total, corresponding to 4.1% of the share capital.

Investor & Media contact
Frederik Svanholm, Group Investment Director, frsv@trifork.com, +41 79 357 7317

About Trifork Group
Trifork (Nasdaq Copenhagen: TRIFOR) is a global technology company specializing in designing, building, and operating advanced software for enterprise and public sector customers. With 1,118 FTEs across 16 countries, Trifork serves as an end-to-end technology partner to organizations in complex and regulated industries, including public administration, healthcare, financial services, energy, and aviation.
Learn more at trifork.com.

Attachment

• CA_61_2026_Buyback